Cargando…

Breast cancer screening in high risk women

Women who are at a significantly raised risk of developing breast cancer should be assessed by a medical geneticist to confirm their history, counselled as to appropriate management and offered breast screening. Currently mammography with magnetic resonance imaging is considered the optimal method o...

Descripción completa

Detalles Bibliográficos
Autor principal: Gilbert, Fiona J.
Formato: Texto
Lenguaje:English
Publicado: e-Med 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582500/
https://www.ncbi.nlm.nih.gov/pubmed/18852075
http://dx.doi.org/10.1102/1470-7330.2008.9002
_version_ 1782160675309617152
author Gilbert, Fiona J.
author_facet Gilbert, Fiona J.
author_sort Gilbert, Fiona J.
collection PubMed
description Women who are at a significantly raised risk of developing breast cancer should be assessed by a medical geneticist to confirm their history, counselled as to appropriate management and offered breast screening. Currently mammography with magnetic resonance imaging is considered the optimal method of early detection of breast cancer in these women. While there is no evidence of mortality benefit there is evidence from surrogate markers that this intervention is worthwhile and cost effective. National recommendations have been produced by the National Institute of Clinical Excellence in the UK and also by the American Cancer Society.
format Text
id pubmed-2582500
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher e-Med
record_format MEDLINE/PubMed
spelling pubmed-25825002010-10-04 Breast cancer screening in high risk women Gilbert, Fiona J. Cancer Imaging Focus on: Breast Cancer Women who are at a significantly raised risk of developing breast cancer should be assessed by a medical geneticist to confirm their history, counselled as to appropriate management and offered breast screening. Currently mammography with magnetic resonance imaging is considered the optimal method of early detection of breast cancer in these women. While there is no evidence of mortality benefit there is evidence from surrogate markers that this intervention is worthwhile and cost effective. National recommendations have been produced by the National Institute of Clinical Excellence in the UK and also by the American Cancer Society. e-Med 2008-10-04 /pmc/articles/PMC2582500/ /pubmed/18852075 http://dx.doi.org/10.1102/1470-7330.2008.9002 Text en © 2008 International Cancer Imaging Society
spellingShingle Focus on: Breast Cancer
Gilbert, Fiona J.
Breast cancer screening in high risk women
title Breast cancer screening in high risk women
title_full Breast cancer screening in high risk women
title_fullStr Breast cancer screening in high risk women
title_full_unstemmed Breast cancer screening in high risk women
title_short Breast cancer screening in high risk women
title_sort breast cancer screening in high risk women
topic Focus on: Breast Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582500/
https://www.ncbi.nlm.nih.gov/pubmed/18852075
http://dx.doi.org/10.1102/1470-7330.2008.9002
work_keys_str_mv AT gilbertfionaj breastcancerscreeninginhighriskwomen